Navigate
X
    QualityStocks
  • 18 years ago

EntreMed, Inc. (NASDAQ: ENMD)

EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company, develops therapeutic candidates mainly for the treatment of cancer and inflammation. The company has focused their efforts on developing drugs that are safe and convenient, and provide the potential for improved patient outcomes. EntreMed’s expertise lies in angiogenesis, cell cycle regulation, cell signaling and inflammation. For further information, visit the Company’s web site at www.entremed.com.

Tags Rodman & Renshaw
Related Post
  1. QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection

    HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored,…

  2. QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Advancing Multi-Pronged Growth Strategy Across Beacon Mill and Swanson Gold Project

    Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. LaFleur…

  3. QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) and Department of Commerce Sign Letter of Intent for $100 Million in CHIPS and Science Act Funding to Accelerate U.S. Leadership in Quantum Computing

    D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), the only dual-platform quantum computing company providing both annealing…